Cytarabine Dose for Acute Myeloid Leukemia REPLY

被引：0
|
作者：
Lowenberg, Bob [1 ]
机构：
[1] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2011年 / 364卷 / 22期
关键词：
CHEMOTHERAPY; THERAPY; INDUCTION; ADULTS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2168 / 2169
页数：2
相关论文
共 50 条
  • [41] Comparison of consolidation strategies in acute myeloid leukemia: high-dose cytarabine alone versus intermediate-dose cytarabine combined with anthracyclines
    Kim, Dae Sik
    Kang, Ka-Won
    Lee, Se Ryeon
    Park, Yong
    Sung, Hwa Jung
    Kim, Seok Jin
    Choi, Chul Won
    Kim, Byung Soo
    ANNALS OF HEMATOLOGY, 2015, 94 (09) : 1485 - 1492
  • [42] Comparison of consolidation strategies in acute myeloid leukemia: high-dose cytarabine alone versus intermediate-dose cytarabine combined with anthracyclines
    Dae Sik Kim
    Ka-Won Kang
    Se Ryeon Lee
    Yong Park
    Hwa Jung Sung
    Seok Jin Kim
    Chul Won Choi
    Byung Soo Kim
    Annals of Hematology, 2015, 94 : 1485 - 1492
  • [43] Autophagy is an important event for low-dose cytarabine treatment in acute myeloid leukemia cells
    Chen, Liyun
    Guo, Pei
    Zhang, Yunxiang
    Li, Xiaoyang
    Jia, Peimin
    Tong, Jianhua
    Li, Junmin
    LEUKEMIA RESEARCH, 2017, 60 : 44 - 52
  • [44] Pharmacological study of modified intermediate-dose cytarabine therapy in patients with acute myeloid leukemia
    Sutoh, H
    Yamauchi, T
    Gotoh, N
    Sugiyama, M
    Ueda, T
    ANTICANCER RESEARCH, 2003, 23 (6D) : 5037 - 5042
  • [45] Low dose cytarabine with or without anthracycline in the induction treatment of elderly patients with acute myeloid leukemia
    Abu-Taleb, F. M.
    Mansour, O. M.
    Khorshid, O. L. A. M. R.
    Raheem, A. Abdel
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S850 - S850
  • [46] Continuous drip infusion therapy of low dose cytarabine and etoposide for hypoplastic acute myeloid leukemia
    Yamada, T
    Tsurumi, H
    Sawada, M
    Kasahara, S
    Hara, T
    Fukuno, K
    Kanemura, N
    Goto, H
    Oyama, M
    Moriwaki, H
    BLOOD, 2002, 100 (11) : 261B - 261B
  • [47] Is Intermediate-Dose Cytarabine a Good Control for Patients with Relapsed or Refractory Acute Myeloid Leukemia?
    Bertoli, Sarah
    Gadaud, Noemie
    Tavitian, Suzanne
    Sarry, Audrey
    Berard, Emilie
    Huguet, Francoise
    Recher, Christian
    BLOOD, 2016, 128 (22)
  • [48] Genetics as predictive marker for consolidation therapy with high-dose cytarabine in acute myeloid leukemia
    Schlenk, Richard F.
    HAEMATOLOGICA, 2024, 109 (06) : 1629 - 1630
  • [49] Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemia
    Graveno, Molly E.
    Carulli, Alison
    Freyer, Craig W.
    Mangan, Brendan L.
    Nietupski, Robert
    Loren, Alison W.
    Frey, Noelle, V
    Porter, David L.
    Gill, Saar, I
    Hexner, Elizabeth O.
    Luger, Selina M.
    Martin, Mary Ellen
    McCurdy, Shannon R.
    Perl, Alexander E.
    Babushok, Daria, V
    Pratz, Keith W.
    LEUKEMIA & LYMPHOMA, 2022, 63 (07) : 1645 - 1650
  • [50] Efficacy and safety of consolidation therapy with intermediate and high dose cytarabine in acute myeloid leukemia patients
    Tangchitpianvit, Kittisak
    Rattarittamrong, Ekarat
    Chai-Adisaksopha, Chatree
    Piriyakhuntorn, Pokpong
    Rattanathammethee, Thanawat
    Hantrakool, Sasinee
    Tantiworawit, Adisak
    Norasetthada, Lalita
    HEMATOLOGY, 2021, 26 (01) : 355 - 364
12345